Literature DB >> 33108268

Obstructive sleep apnea during rapid eye movement sleep in patients with diabetic kidney disease.

Akihiro Nishimura1, Takatoshi Kasai2,3, Kimio Matsumura1, Shota Kikuno1, Kaoru Nagasawa1, Minoru Okubo1, Koji Narui2, Yasumichi Mori1.   

Abstract

STUDY
OBJECTIVES: Although recent studies suggest that obstructive sleep apnea during rapid eye movement (REM) is associated with different cardiometabolic and neurocognitive risks compared with non-REM (NREM) sleep, there is no information on whether obstructive sleep apnea during REM and/or NREM sleep is independently associated with diabetic kidney disease (DKD).
METHODS: In this cross-sectional study, 303 patients with type 2 diabetes who were followed up at our diabetes outpatient clinic underwent all-night polysomnography. Logistic regression analysis was performed to determine the separate effects of obstructive sleep apnea during REM and/or NREM sleep (REM and/or NREM-apnea-hypopnea index [AHI]) and several other polysomnography parameters on DKD after adjustment for several known risk factors for DKD.
RESULTS: The median (interquartile range) AHI, REM-AHI, and NREM-AHI of the patients (age 57.8 ± 11.8 years, male sex 86.8%, hypertension 64.3%, and DKD 35.2%) were 29.8 (18.0-45.4), 35.4 (21.1-53.3), and 29.1 (16.3-45.4) events/h, respectively. REM-AHI quartiles, but not NREM-AHI quartiles, correlated independently and significantly with DKD (P = .03 for linear trend, odds ratio (OR), and 95% confidence interval for Q2: 3.14 (1.10-8.98), Q3: 3.83 (1.26-11.60), Q4: 4.97 (1.60-15.46), compared with Q1). In addition, categorical AHI (P = .01, OR, and 95% confidence interval for ≥ 15 to < 30: 1.54 (0.64-3.71), ≥ 30: 3.08 (1.36-6.94) compared with < 15), quartiles of AHI (P = .01), quartiles of lowest arterial oxyhemoglobin saturation (P < .01), quartiles of percentage of time spent with arterial oxyhemoglobin saturation < 90 (P < .01), and quartiles of mean arterial oxyhemoglobin saturation were independently associated with DKD.
CONCLUSIONS: Obstructive sleep apnea, especially during REM sleep, is a potential risk factor for DKD.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  diabetic angiopathy; diabetic kidney disease; rapid eye movement sleep; sleep apnea syndrome; sleep disorders; type 2 diabetes

Mesh:

Year:  2021        PMID: 33108268      PMCID: PMC7927344          DOI: 10.5664/jcsm.8924

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  45 in total

1.  Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes.

Authors:  Babak Mokhlesi; Daniela Grimaldi; Guglielmo Beccuti; Eve Van Cauter
Journal:  Diabetes Obes Metab       Date:  2016-12-12       Impact factor: 6.577

2.  Obstructive sleep apnea during REM sleep and hypertension. results of the Wisconsin Sleep Cohort.

Authors:  Babak Mokhlesi; Laurel A Finn; Erika W Hagen; Terry Young; Khin Mae Hla; Eve Van Cauter; Paul E Peppard
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

3.  The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients.

Authors:  Semaan Kosseifi; Beth Bailey; Robert Price; Thomas M Roy; Ryland P Byrd; Alan N Peiris
Journal:  Mil Med       Date:  2010-11       Impact factor: 1.437

4.  Relationship between sleep disordered breathing and diabetic retinopathy: Analysis of 136 patients with diabetes.

Authors:  Akihiro Nishimura; Takatoshi Kasai; Haruko Tamura; Azusa Yamato; Daijiro Yasuda; Kaoru Nagasawa; Minoru Okubo; Koji Narui; Yasumichi Mori
Journal:  Diabetes Res Clin Pract       Date:  2015-05-12       Impact factor: 5.602

5.  Hypoxic ventilatory response decreases during sleep in normal men.

Authors:  N J Douglas; D P White; J V Weil; C K Pickett; R J Martin; D W Hudgel; C W Zwillich
Journal:  Am Rev Respir Dis       Date:  1982-03

6.  Hypertension Is Associated With Undiagnosed OSA During Rapid Eye Movement Sleep.

Authors:  Sarah L Appleton; Andrew Vakulin; Sean A Martin; Carol J Lang; Gary A Wittert; Anne W Taylor; R Doug McEvoy; Nick A Antic; Peter G Catcheside; Robert J Adams
Journal:  Chest       Date:  2016-03-19       Impact factor: 9.410

7.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

Review 8.  Obstructive sleep apnoea in diabetes: Does it matter?

Authors:  Abd A Tahrani
Journal:  Diab Vasc Dis Res       Date:  2017-06-14       Impact factor: 3.291

9.  Obstructive sleep apnea and diabetic nephropathy: a cohort study.

Authors:  Abd A Tahrani; Asad Ali; Neil T Raymond; Safia Begum; Kiran Dubb; Quratul-Ain Altaf; Milan K Piya; Anthony H Barnett; Martin J Stevens
Journal:  Diabetes Care       Date:  2013-09-23       Impact factor: 19.112

10.  Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications.

Authors:  Daniela Grimaldi; Guglielmo Beccuti; Carol Touma; Eve Van Cauter; Babak Mokhlesi
Journal:  Diabetes Care       Date:  2013-10-07       Impact factor: 19.112

View more
  1 in total

1.  Therapeutic effect of laparoscopic sleeve gastrectomy on obstructive sleep apnea and relationship of type 2 diabetes in Japanese patients with severe obesity.

Authors:  Shingo Yanari; Akira Sasaki; Akira Umemura; Yasushi Ishigaki; Haruka Nikai; Tsuguo Nishijima; Shigeru Sakurai
Journal:  J Diabetes Investig       Date:  2022-02-08       Impact factor: 3.681

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.